Impact Factor: 7.883
Submit Paper
Volume 8, Issue 7 (July 2022)

Formulation And Evaluation Of Fast Disintegrating Tablet Of Solid Dispersion Of Irbesartan

Impact Factor
7.883
Call For Paper
Volume 12 Issue 07

July 2026

Download Paper Format
Copyright Form
Share on:

Author(s)

Monika H. Kale Mrs. Trusha P. Shangrapawar Dr.Ashok Bhosale

Abstract

Irbesartan Is An Angiotensin Receptor Blocker Used To Treat Hypertension And Diabetic Nephropathy. In Present Study, The Attempts Have Been Made To Increase The Dissolution Of BCS Class II Drug Irbesartan Using Hydrophilic Polymers HPMC And Polyethylene


Keywords

Irbesartan Fast Disintegrating Tablet Solid Dispersions Kneading Method Microwave Induced Fusion Method Superdisintegrants.

Paper ID

IJSARTV8I755529

Publication Date

July 4, 2022

Research Area

PHARMACY

Submit Your Paper to IJSART

Join the global research community with IJSART. Submit your paper, share your work, and gain worldwide recognition!